Ensitrelvir (Zokovea)
Post exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older
2 trials are being summarised and will appear here shortly.
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Post exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older
2 trials are being summarised and will appear here shortly.
To use as post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) following contact with an individual who has COVID-19